A defective Epstein-Barr virus (EBV) containing a deleted and rearranged genome (het DNA) causes latent EBV to replicate. This activity maps to the 2. Previous work identified an EBV gene product that switches the virus from latency into replication (12) (13) (14) (15) Fig. 2 legend) .
HR-1 viruses to disrupt latency of the standard EBV genome is due to abnormal regulation of the BZLF1 gene as a result of genomic rearrangements.
Many viruses establish persistent lifelong infections within their hosts. One mode of persistence, latency, requires selective repression of viral gene expression. Mechanisms are required to overcome this inhibition to replicate progeny virus particles that can spread within the host and infect other individuals. This report concerns the transition between the latent and replicative life cycles of Epstein-Barr virus (EBV) as studied in B lymphocytes. During latency, EBV expresses a limited number of genes (currently estimated at 10), while during replication there is expression of many viral genes leading to production of infectious virus (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) .
Previous work identified an EBV gene product that switches the virus from latency into replication (12) (13) (14) (15) . This polypeptide, encoded within the BZLF1 open reading frame, is called ZEBRA (BamHI Z, EBV replication activator) (16) . Introducing BZLF1 sequences, cloned in vectors with strong heterologous promoters, activates EBV replication in latently infected cells. While all plasmids containing BZLF1 driven by heterologous promoters are able to activate replication, EBVs differ in their capacity to switch between latency and replication (17) (18) (19) . Standard EBVs remain latent in most lymphoid cells, although the replicative cycle can be induced by stimuli such as phorbol esters or butyrate (20, 21) . Certain defective EBVs with deleted and rearranged genomes do not establish latency. When such viruses are added to cells in which the standard EBV is latent, they transactivate the latent genome, causing it to replicate (17, 18) .
Two mechanisms could explain biologic differences between standard and defective viruses. Point mutations between ZEBRA polypeptides from standard and defective viruses might account for different levels of activity of the protein (13) . More plausibly, the ZEBRA gene may be aberrantly regulated in the defective virus because of rearrangements in the het genome (22) (23) (24) (13) . Subfragments of EcoRI het 16 were prepared (see Fig. 2 legend) .
Transfection. Stationary-phase cells were exposed for 30 min at 37°C to 1-5 ug of DNA in RPMI medium containing 100 ,ug of DEAE-dextran per ml. Thereafter, cells were washed and resuspended in conditioned growth medium with or without phorbol 12-myristate 13-acetate (PMA) at 4 ng/ml for 48 hr.
Polypeptide Detection. ZEBRA was detected by Western blotting with monospecific antibodies raised in rabbits immunized with a TrpE-BZLF1 fusion protein (N.T., J.C., C.R., D. Katz, and G.M., unpublished data). Replicative polypeptides were detected with human WC antiserum (26) .
RESULTS
Rearranged Sequences from BamHI W Enhance ZEBRA Expression After Transfection of BL Cells. Countryman et al. had shown that rearranged sequences in WZhet did not contribute to the structural gene for the ZEBRA protein nor were they obligatory for activating EBV replication in a somatic cell hybrid (D98/HR-1) (13) . These conclusions were based on the use ofdeletion mutants in which sequences were progressively removed from the BamHI W region of pSV2neo WZhet (Fig. 1 A and B) .
To determine whether rearranged sequences from BamHI W affected expression of ZEBRA in B cells the same mutants were transfected into BL41/CL16 cells. Expression of ZEBRA was monitored 48 hr after transfection by using monospecific anti-BZLF1 antibody (Fig. 1C) (Fig. 3) . Recipient cells were BL41, which lacked an EBV genome, or BL41/CL16, which carried a latent EBV genome (Fig. 3) . In both types of cells, the EcoRI het 16 palindrome cloned on pACYC184 expressed ZEBRA at similar levels as did WZhet driven by the SV40 promoter/enhancer. Expression of ZEBRA was greater in stably converted BL41/CL16 cells with a latent EBV genome than in EBV genome-negative BL41 cells (compare Fig. 3 A and B) . Expression of ZEBRA could not be detected in BL41 cells transfected with pBR322 WZhet or with pSV2neo carrying BamHI Z (Fig. 3A) . In BL41 cells, ZEBRA expression from WZhet was thus dependent on both the heterologous SV40 promoter and the BamHI W sequences. However, the requirement for the heterologous promoter could be overcome by using the entire EcoRI het 16 Fig. 2 ). In BL41 cells pMM277 produced a weak, but definite, signal of ZEBRA expression, which was seen in the presence ofPMA (Fig. 4 B and C; data not shown). Since ZEBRA was never expressed from pBR WZhet in BL41 cells ( Fig. 3 ; data not shown), these results suggested that plasmids containing the central palindromic BamHI W sequences contained additional signals that increased ZEBRA production. Expression from pMM445, which contains two copies of WZhet as well as the central portion of the palindrome, was slightly stronger than that from pMM277, which contains only one copy (data not shown). However, neither plasmid was as active as EcoRI het 16 (Fig. 4) . To determine whether the higher level of expression of ZEBRA observed after transfection with EcoRI het 16 by comparison to pMM277 was the result of production of additional polypeptides synthesized by the larger of the two fragments of het DNA, immunoblots of BL41 cells transfected with EcoRI het 16 were probed with polyvalent human antisera (WC and Marshall) that are highly reactive to many EBV replicative products (6) . The predominant polypeptide Fig. 1A ). Dotted line indicates the MS-early antigen, which is composed of one exon from BSLF2 and another from BMLF1 (30, 31 identified after transfection ofEcoRI het 16 was ZEBRA (Fig.  4 C and D) .
Comparison of ZEBRA Expression by EcoRI het 16 and pMM277 in Cells with an Endogenous EBV Genome. In BL41/CL16 cells consistently higher levels of ZEBRA were made by EcoRI het 16 than by pMM277 (Fig. 5A) . When the EBV inserts in both plasmids were excised, ZEBRA expression was unaffected. The results show that promoter/enhancer systems functional in B cells are found on both fragments of defective DNA but are more active in the larger palindrome.
EcoRI het 16 contains additional open reading frames, BSLF1, BSLF2, and BMLF1 (truncated at its carboxyl end), which are not present in pMM277 or pMM445 (see Fig. 2 ). Some ofthese sequences encode trans-activators (30, 31) . We looked for trans-activating effects of the downstream sequences within EcoRI het 16 by cotransfecting pMM277 with a pSV2neo plasmid (pJJ859) that contains these additional sequences (see Fig. 2 ). When these plasmids were cotransfected into BL41/CL16 cells (Fig. 5B) , no enhancement of ZEBRA expression or latency disruption was observed. DISCUSSION
A number of findings help to explain the capacity of HR-1 virus containing het DNA to disrupt latency. Rearrangements of EBV genomic sequences in het DNA allow the expression of the ZEBRA gene product, which induces virus replication. Rearrangements that are important involve sequences from IR1 (BamHI W), which have been repositioned upstream of BZLF1 ( Fig. 1; refs. 3 and 5-7) as well as sequences from BamHI S and M, which are now in closer proximity downstream of BZLF1 than they are in the standard genome (Fig.  2) . Furthermore, a 16-kbp palindrome of het DNA reproduced the latency disrupting effects of defective HR-1 virus without requiring any promoter/enhancer system derived from another virus ( Fig. 3 ; data not shown). In addition, the level of ZEBRA product was shown to correlate with the extent of expression of induced replicative polypeptides (Fig.  1) . The effects of EBV regulatory regions on expression of EBV genes were studied in human BL cells, which are a natural host for the virus.
Effects of Translocated IRi Sequences on ZEBRA Expression. Sequences from IR1 were partly responsible for the high levels of ZEBRA expression by defective viral DNA. Deletion of IR1 sequences reduced the ability of transfected plasmids with the SV40 promoter to express ZEBRA (Figs.  1 and 3) . Plasmids that contained the central palindromic portion of IR1 plus WZhet could function in both BL41 and BL41/CL16 cells independent of any heterologous promoter/enhancer (Figs. 4 and 5) .
Regions of IR1 that are thought to be important in control of expression of latent genes in standard EBV are partially or totally excluded from het DNA. A 458 and the sequence 5'-GGACTTT-3' located at bp 820. These are similar to the consensus 5'-RGGGACTTTCC-3' (R = purine), which is present in the immunoglobulin K-chain enhancer and in several viral enhancers including cytomegalovirus and human immunodeficiency virus. This motif forms a binding site for the NF-KB transcription factor (35) .
Other Signals in EcoRI het 16 That Affect ZEBRA Expression. Expression of ZEBRA from EcoRI het 16 was much more efficient than from plasmids lacking downstream sequences from BamHI M and S (Figs. 4 and 5 ). This increased ZEBRA expression is unlikely to result from additional trans-active products encoded within EcoRI het 16 since levels of ZEBRA expression were not altered by supplying sequences downstream of BZLF1 in trans (Fig. 5) 
